Eli Health key facts
as of Oct 2026- Developer of a hormone monitoring kit designed for real-time health insights.
- Eli Health is valued at approximately $25.6M as of Oct 2026 (last reported valuation).
- It has raised $30.3M; the latest was Accelerator/Incubator in Jan 2026.
- Notable investors include Techstars, Flybridge (New York), BDC Capital, Garage Capital, 2048 Ventures — 31 tracked in total.
- Status: Privately Held (backing).
Eli Health's last reported valuation, May 2025. Nothing priced has surfaced since.
- ·The complete investor list: 31 names
- ·Watch Eli Health: the Monday email on marks, rounds and moves
Eli Health funding rounds
No funding rounds for Eli Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Eli Health
31+Eli Health valuation
Eli Health's last reported valuation was $25.6 million in May 2025. No priced round, secondary trade or fund mark has surfaced since.
Eli Health investors
31 investors are on record for Eli Health, including Techstars, Flybridge (New York), BDC Capital and Garage Capital. By type, the record holds 6 venture capital firms and 1 growth equity firm.
About Eli Health
Developer of a hormone monitoring kit designed for real-time health insights. The company offers saliva-based testing technology to continuously track hormone levels, offering features such as cortisol and progesterone monitoring, personalized guidance, and daily data-driven insights, enabling women to proactively manage their hormonal health and improve overall well-being through accessible and innovative technology.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2019
- Employees
- 27
- Website
- eli.health/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.